Marguerite Buchanan

2.6k citations

22 papers · 2.0k indexed · 1 hit paper · h-index 13

Molecular Biology top 5%
Cancer Research top 2%
Oncology top 10%
Genetics top 5%
Immunology top 10%

Co-authors: Mark Basik Abdel Hosein Valbona Luga Elaine Chiu Liang Zhang Abiodun A. Ogunjimi Jeffrey L. Wrana Alicia Viloria‐Petit
Topics: Cancer Cells and Metastasis (5 papers)HER2/EGFR in Cancer Research (5 papers)Cancer Genomics and Diagnostics (4 papers)
Cited by: Cancer Research Genetics Molecular Biology
Journals: Cell Proceedings of the National Academy of Sciences Nature Communications
Partner nations: Canada United States United Kingdom

In The Last Decade

Marguerite Buchanan

22 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosomes Mediate Stromal Mobilization of Autocrine Wnt-PCP Signaling in Breast Cancer Cell Migration

2012 1.1k citations Valbona Luga, Liang Zhang et al. Cell profile →

Peers

Countries citing papers authored by Marguerite Buchanan

Since Specialization

Citations

This map shows the geographic impact of Marguerite Buchanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marguerite Buchanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marguerite Buchanan more than expected).

Fields of papers citing papers by Marguerite Buchanan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marguerite Buchanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marguerite Buchanan. The network helps show where Marguerite Buchanan may publish in the future.

Co-authorship network of co-authors of Marguerite Buchanan

This figure shows the co-authorship network connecting the top 25 collaborators of Marguerite Buchanan. A scholar is included among the top collaborators of Marguerite Buchanan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marguerite Buchanan. Marguerite Buchanan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	3D chromatin remodeling potentiates transcriptional programs driving cell invasion 2022 ·Proceedings of the National Academy of Sciences ·(unknown),Maïka Jangal,Tiejun Zhao,Cheng Kit Wong,(unknown),(unknown),Steven Hébert,Adriana Aguilar‐Mahecha,Catherine Chabot,Marguerite Buchanan,(unknown),Luke McCaffrey,Geneviève Deblois,Claudia L. Kleinman,Morag Park,Mark Basik,Michael Witcher	10
2	Precise Quantitation of PTEN by Immuno-MRM: A Tool To Resolve the Breast Cancer Biomarker Controversy 2021 ·Analytical Chemistry ·Sahar M. Ibrahim,Cathy Lan,Catherine Chabot,(unknown),Marguerite Buchanan,Adriana Aguilar‐Mahecha,Mounib Elchebly,Oliver Poetz,Alan Spatz,Mark Basik,Gerald Batist,René P. Zahedi,Christoph H. Borchers	9
3	Metastatic Breast Carcinoma–Associated Fibroblasts Have Enhanced Protumorigenic Properties Related to Increased IGF2 Expression 2019 ·Clinical Cancer Research ·(unknown),Adriana Aguilar‐Mahecha,(unknown),Abdel Hosein,Marguerite Buchanan,Josiane Lafleur,Michaël Pollak,Cristiano Ferrario,Mark Basik	34
4	An integrated stress response via PKR suppresses HER2+ cancers and improves trastuzumab therapy 2019 ·Nature Communications ·(unknown),(unknown),Catherine Chabot,(unknown),Siham Sabri,Shuo Wang,(unknown),Marguerite Buchanan,Adriana Aguilar‐Mahecha,Bassam Abdulkarim,Jean Deschênes,José Torres,Josie Ursini‐Siegel,Mark Basik,Antonis E. Koromilas	48
5	Precision Medicine Tools to Guide Therapy and Monitor Response to Treatment in a HER-2+ Gastric Cancer Patient: Case Report 2019 ·Frontiers in Oncology ·Adriana Aguilar‐Mahecha,(unknown),Luca Cavallone,Marguerite Buchanan,(unknown),Gerald Batist,Mark Basik	6
6	Leukocytes as a reservoir of circulating oncogenic DNA and regulatory targets of tumor‐derived extracellular vesicles 2018 ·Journal of Thrombosis and Haemostasis ·Shilpa Chennakrishnaiah,Brian Meehan,Esterina D’Asti,Laura Montermini,Tae Hoon Lee,(unknown),Marguerite Buchanan,Nadim Tawil,Dongsic Choi,Maziar Divangahi,Mark Basik,Janusz Rak	55
7	Abstract 5894: Stromal fibroblasts from metastatic breast cancer promote proliferation and migration of breast cancer cell and regulate its stemness 2017 ·Cancer Research ·(unknown),Adriana Aguilar‐Mahecha,Marguerite Buchanan,Mark Basik	1
8	The crosstalk between breast carcinoma-associated fibroblasts and cancer cells promotes RhoA-dependent invasion via IGF-1 and PAI-1 2017 ·Oncotarget ·Julien Daubriac,Shiwei Han,Jelena Grahovac,(unknown),Abdel Hosein,Marguerite Buchanan,Mark Basik,Yves Boucher	33
9	The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers 2015 ·Cancer Research ·(unknown),Luca Cavallone,Aline Mamo,Catherine Chabot,Isabelle Sirois,Anthony M. Magliocco,Alexander C. Klimowicz,Patricia N. Tonin,Marguerite Buchanan,(unknown),Saima Hassan,David Laperrière,Sylvie Mader,Olga Aleynikova,Mark Basik	41
10	A functional in vitro model of heterotypic interactions reveals a role for interferon-positive carcinoma associated fibroblasts in breast cancer 2015 ·BMC Cancer ·Abdel Hosein,Julie Livingstone,Marguerite Buchanan,James F. Reid,Michael Hallett,Mark Basik	18
11	RSF1 and Not Cyclin D1 Gene Amplification May Predict Lack of Benefit from Adjuvant Tamoxifen in High-Risk Pre-Menopausal Women in the MA.12 Randomized Clinical Trial 2013 ·PLoS ONE ·(unknown),Marguerite Buchanan,(unknown),Olga Aleynikova,Dongsheng Tu,Xiao Li,Lois E. Shepherd,Vivien Bramwell,Mark Basik	8
12	Exosomes Mediate Stromal Mobilization of Autocrine Wnt-PCP Signaling in Breast Cancer Cell Migrationbreakdown → 2012 ·Cell ·Valbona Luga,Liang Zhang,Alicia Viloria‐Petit,Abiodun A. Ogunjimi,(unknown),Elaine Chiu,Marguerite Buchanan,Abdel Hosein,Mark Basik,Jeffrey L. Wrana	1089
13	Making personalized medicine a reality: the challenges of a modern translational research biopsy-driven program in an academic setting: the Segal Cancer Center experience 2011 ·Adriana Aguilar‐Mahecha,Zuanel Diaz,Marguerite Buchanan,Cristiano Ferrario,A. Lisbona,(unknown),Carole Seguin‐Devaux,Mark Basik	2
14	CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti‐VEGF treatment or docetaxel in a transgenic mouse model 2010 ·International Journal of Cancer ·Saima Hassan,Marguerite Buchanan,Kaushar Jahan,Adriana Aguilar‐Mahecha,Louis Gaboury,William J. Muller,(unknown),(unknown),Peter M. Siegel,Ombretta Salvucci,Mark Basik	99
15	Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Inhibiting CD4 Th17 T Cells in a CC Chemokine Ligand 2-Dependent Manner 2009 ·The Journal of Immunology ·Moutih Rafei,Philippe M. Campeau,Adriana Aguilar‐Mahecha,Marguerite Buchanan,Patrick Williams,Elena Birman,Shala Yuan,Yoon Kow Young,Marie‐Noëlle Boivin,Kathy Forner,Mark Basik,Jacques Galipeau	296
16	Both t-Darpp and DARPP-32 can cause resistance to trastuzumab in breast cancer cells and are frequently expressed in primary breast cancers 2009 ·Breast Cancer Research and Treatment ·(unknown),Amélie Bouchard,Cristiano Ferrario,Saima Hassan,Adriana Aguilar‐Mahecha,Marguerite Buchanan,Louise Quenneville,Wilson H. Miller,Mark Basik	47
17	Proteomic Analysis of Human Plasma Proteins by Two-Dimensional Gel Electrophoresis and by Antibody Arrays Following Depletion of High-Abundance Proteins 2007 ·Cell Biochemistry and Biophysics ·Richard R. Desrosiers,Édith Beaulieu,Marguerite Buchanan,Richard Béliveau	21
18	Health and cancer prevention: knowledge and beliefs of children and young people 1995 ·BMJ ·Ann Oakley,Gillian Bendelow,(unknown),Marguerite Buchanan,O. A. N. Husain	94
19	Sodium dodecyl sulphate‐polyacrylamide gel electrophoresis of human parotid salivary proteins 1991 ·Electrophoresis ·J.A. Beeley,(unknown),(unknown),Marguerite Buchanan,(unknown),Kong Soo Khoo	90
20	An apparatus for four-point bending fatigue testing of materials in a scanning electron microscope and its application to nodular cast iron 1987 ·Metallography ·Marguerite Buchanan,J. W. Provan,J. E. Gruzleski	2

About Marguerite Buchanan

Marguerite Buchanan is a scholar working on Oncology, Cancer Research and Genetics, having authored 22 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (5 papers), HER2/EGFR in Cancer Research (5 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Cancer Research (770 citations), Genetics (292 citations) and Molecular Biology (1.3k citations). Marguerite Buchanan has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Mark Basik, Abdel Hosein, Valbona Luga, Elaine Chiu, Liang Zhang, Abiodun A. Ogunjimi, Jeffrey L. Wrana, Alicia Viloria‐Petit, Adriana Aguilar‐Mahecha and Philippe M. Campeau. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact